Japan Drug Delivery Devices Market

Japan’s drug delivery devices market accounted USD XX billion in 2016 and is expected to reach USD XX billion by 2020, growing at a CAGR of XX% during the forecast period. Japan has one of the world’s most advanced healthcare facilities. The healthcare administration in Japan is also becoming a model for many developing nations.

Japan Drug Delivery Devices Market-Market Dynamics

The report details several factors driving and restraining the market, some of which are listed below.

Drivers

• Increased prevalence of chronic diseases
• Advances in drug delivery system
• Increase in individual therapy
• Increased understanding about drug metabolism among the population
• Increasing demand for generic drugs
• Requirement of controlled drug release

Restraints

Product recalls and stringent regulatory framework are turning out to be restraints for this market.

Japan’s drug delivery market has been segmented into oral drug delivery systems, nasal drug delivery system, pulmonary drug delivery system, injectable drug delivery, ocular drug delivery, topical drug delivery, transmucosal drug delivery and implantable drug delivery. The segmentation on oral drug delivery system is sub-divided into solid oral drugs (includes tablets, capsules, powders, and pills), liquid oral drugs (includes syrups and solutions), semi-solid oral drugs (includes gels, emulsions, suspensions, and elixirs). The segmentation on nasal drug delivery systems has been subdivided into nasal drops, nasal sprays, nasal powders, nasal gels. The segmentation on pulmonary drug delivery systems includes metered dose inhalers, dry powder inhalers, and nebulizers. The segmentation on injectable drug delivery has been further segmented into general injectable, self -injection device, needle-free injectors, auto-injectors, and pen injectors.

The injectable drug delivery segment has also been sub-divided based on materials, products (includes fillable syringe, and prefilled syringes) and usability (includes reusable syringe and disposable syringes). The segmentation on ocular drug delivery includes liquid ocular drug delivery, semi-solid ocular drug delivery, and ocular devices. The segmentation based on topical drug delivery has been segmented into liquid topical drug delivery (includes suspensions and solutions), semi-solid topical drug delivery (includes creams, gels, pastes, ointments, and lotions), and solid topical drug delivery (includes suppositories and powders). The segmentation on transmucosal drug delivery has been segmented into buccal drug delivery, sublingual drug delivery, rectal transmucosal drug delivery, and vaginal transmucosal drug delivery.

Some of the key players in the market are:

• 3M Company
• F. Hoffmann- La Roche Ltd.
• GlaxoSmithKline
• Johnson and Johnson
• Novartis AG
• Pfizer
• Sanofi

Key Deliverables of the Study

• Market definition along with identification of key drivers and restraints for the market.
• Market analysis for Japan’s drug delivery devices market, with region-specific assessments and competition analysis.
• Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market.
• Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
• Identification and analysis of the macro and micro factors that affect Japan’s drug delivery devices market on a regional scale.
• A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.